GSK Takes Lupin To Court To Block Generic Combivir Launch in the U.S.
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Europe's largest drugmaker GlaxoSmithKline has sued Indian drug maker Lupin for infringement of its patents for anti-AIDS drug Combivir in the U.S